Showing results (321-330 of 9,052) with videos related to
Sort By:
Pageof 906
Rheumatology (Oxford, England)|May 5, 2022
Musculoskeletal ultrasound for treating rheumatoid arthritis to target-a systematic literature reviewEttore Silvagni, Sara Zandonella Callegher, Eleonora Mauric, et al.Rheumatology (Oxford, England)|May 5, 2022
Reclassification of previously diagnosed GPA patients using the 2022 ACR/EULAR classification criteriaJung Yoon Pyo, Sung Soo Ahn, Jason Jungsik Song, et al.Rheumatology (Oxford, England)|May 5, 2022
Thigh MRI in antisynthetase syndrome, and comparisons with dermatomyositis and immune-mediated necrotizing myopathyWenhao Zhang, Yiming Zheng, Yikang Wang, et al.Rheumatology (Oxford, England)|March 18, 2022
Associations between syndesmophytes and facet joint ankylosis in radiographic axial spondyloarthritis patients on low-dose CT over 2 yearsRosalinde Stal, Alexandre Sepriano, Floris Alexander van Gaalen, et al.Rheumatology (Oxford, England)|October 2, 2021
Serum lipidomics reveals distinct metabolic profiles for asymptomatic hyperuricemic and gout patientsShijia Liu, Yingzhuo Wang, Huanhuan Liu, et al.Rheumatology (Oxford, England)|October 26, 2021
Plasma exosomal RNAs have potential as both clinical biomarkers and therapeutic targets of dermatomyositisLiya Li, Xiaoxia Zuo, Di Liu, et al.Rheumatology (Oxford, England)|October 26, 2021
Rituximab plus methotrexate combination as a salvage therapy in persistently active granulomatosis with polyangiitisBoris Sorin, Maxime Samson, Cécile-Audrey Durel, et al.Rheumatology (Oxford, England)|October 14, 2021
Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trialWalter P Maksymowych, Mikkel Østergaard, Robert Landewé, et al.Rheumatology (Oxford, England)|January 25, 2022
Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisisHideaki Tsuji, Nobuo Kuramoto, Tsuneo Sasai, et al.Rheumatology (Oxford, England)|April 12, 2022
Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-upWeike Luo, Filipa Farinha, David A Isenberg, et al.Pageof 906